Clinical trial
Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach
NCT06877260 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach
- Lead sponsor
- IRCCS Eugenio Medea
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 1, 2024
- Completion date
- November 1, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, neurodevelopmental disorder (diagnosis)